Screener
Veracyte VCYT Business Segments — G&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Veracyte’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:07 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001384101-26-000031
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Compensation expense | 16,236 | 20,173 |
| Other general and administrative expenses (6) | 13,471 | 21,890 |
| Allocation of facilities and IT expenses | (6,027) | (8,255) |
| Total general and administrative | 23,680 | 33,808 |
| Intangible asset amortization - operating expenses | 579 | 622 |
| Other income, net | (7,328) | (4,524) |
| Income tax provision | 1,267 | 381 |
| Net income | $28,707 | $7,047 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Veracyte's business segments — G&A?
- Veracyte (VCYT) reported business segments — G&A of $23.68M in Q1 2026.
- How has Veracyte's business segments — G&A changed year-over-year?
- Veracyte's business segments — G&A decreased by 30.0% year-over-year, from $33.81M to $23.68M.
- What is the long-term trend for Veracyte's business segments — G&A?
- Over 3 years (2022 to 2025), Veracyte's business segments — G&A has grown at a 14.8% compound annual growth rate (CAGR), from $73.2M to $110.78M.
- What does business segments — G&A mean?
- This metric aggregates the total costs associated with the administrative, executive, and support functions of the reportable segment. It reflects the overhead required to manage the segment's day-to-day operations, including personnel, facilities, and corporate governance. Tracking this figure is essential for evaluating the segment's operational leverage and cost structure.
Ask your AI about Veracyte's business segments — g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude